Understanding of Clinical Trials Among Patients With Cancer and Their Relatives
2025 · JAMA Network Open · 6 citations
https://doi.org/10.1001/jamanetworkopen.2024.57020
P
Pınar Kubilay Tolunay
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
24
Citations
3
h-index
0
i10-index
Pınar Kubilay Tolunay is an academic researcher from Ankara University. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Breast Cancer Treatment Studies. The author has an h-index of 3, co-authored 29 publications.
ORCID: 0000-0003-2636-5326Papers by this author
worksReal-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial
2024 · Targeted Oncology · 3 citations
https://doi.org/10.1007/s11523-024-01095-4
Impact of the CPS-EG score as a new prognostic biomarker in triple-negative breast cancer patients who received neoadjuvant chemotherapy
2024 · BMC Cancer · 3 citations
https://doi.org/10.1186/s12885-024-13100-0
A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy
2025 · Medicina · 1 citations
https://doi.org/10.3390/medicina61020360
Fibroblast Growth Factor Receptor (FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic Developments and Knowledge Gaps
2026 · Drug Design Development and Therapy · 0 citations
https://doi.org/10.2147/dddt.s559328
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat